278 related articles for article (PubMed ID: 21110812)
1. Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment.
Russo P; Cesario A; Rutella S; Veronesi G; Spaggiari L; Galetta D; Margaritora S; Granone P; Greenberg DS
Curr Med Chem; 2011; 18(1):91-112. PubMed ID: 21110812
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic receptor antagonists as treatments for nicotine abuse.
Crooks PA; Bardo MT; Dwoskin LP
Adv Pharmacol; 2014; 69():513-51. PubMed ID: 24484986
[TBL] [Abstract][Full Text] [Related]
3. Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction.
Rahman S; López-Hernández GY; Corrigall WA; Papke RL
CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):422-41. PubMed ID: 19128201
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein.
Rucktooa P; Haseler CA; van Elk R; Smit AB; Gallagher T; Sixma TK
J Biol Chem; 2012 Jul; 287(28):23283-93. PubMed ID: 22553201
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of varenicline for smoking cessation.
Hays JT; Ebbert JO; Sood A
Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
[TBL] [Abstract][Full Text] [Related]
6. Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review.
Leeman RF; Huffman CJ; O'Malley SS
Alcohol Alcohol; 2007; 42(3):196-206. PubMed ID: 17526629
[TBL] [Abstract][Full Text] [Related]
7. Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions.
Greenbaum L; Lerer B
Mol Psychiatry; 2009 Oct; 14(10):912-45. PubMed ID: 19564872
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Benowitz NL
Clin Pharmacol Ther; 2008 Apr; 83(4):531-41. PubMed ID: 18305452
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underlying behaviors related to nicotine addiction.
Picciotto MR; Kenny PJ
Cold Spring Harb Perspect Med; 2013 Jan; 3(1):a012112. PubMed ID: 23143843
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.
Benowitz NL
Annu Rev Pharmacol Toxicol; 2009; 49():57-71. PubMed ID: 18834313
[TBL] [Abstract][Full Text] [Related]
11. Tobacco habit: historical, cultural, neurobiological, and genetic features of people's relationship with an addictive drug.
Russo P; Nastrucci C; Alzetta G; Szalai C
Perspect Biol Med; 2011; 54(4):557-77. PubMed ID: 22019540
[TBL] [Abstract][Full Text] [Related]
12. Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research.
Portugal GS; Gould TJ
Behav Brain Res; 2008 Nov; 193(1):1-16. PubMed ID: 18571741
[TBL] [Abstract][Full Text] [Related]
13. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Rollema H; Hurst RS
Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
[TBL] [Abstract][Full Text] [Related]
14. Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism.
Wen L; Jiang K; Yuan W; Cui W; Li MD
Mol Neurobiol; 2016 Jan; 53(1):472-484. PubMed ID: 25471942
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
Pintarelli G; Galvan A; Pozzi P; Noci S; Pasetti G; Sala F; Pastorino U; Boffi R; Colombo F
Sci Rep; 2017 Dec; 7(1):16730. PubMed ID: 29196725
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
Florek E; Piekoszewski W
Przegl Lek; 2008; 65(10):700-5. PubMed ID: 19189582
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
Bergen AW; Javitz HS; Krasnow R; Nishita D; Michel M; Conti DV; Liu J; Lee W; Edlund CK; Hall S; Kwok PY; Benowitz NL; Baker TB; Tyndale RF; Lerman C; Swan GE
Pharmacogenet Genomics; 2013 Feb; 23(2):94-103. PubMed ID: 23249876
[TBL] [Abstract][Full Text] [Related]
18. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.
Rollema H; Coe JW; Chambers LK; Hurst RS; Stahl SM; Williams KE
Trends Pharmacol Sci; 2007 Jul; 28(7):316-25. PubMed ID: 17573127
[TBL] [Abstract][Full Text] [Related]
19. Nicotine dependence and smoking cessation.
Tan L; Tang Q; Hao W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1049-57. PubMed ID: 19952392
[TBL] [Abstract][Full Text] [Related]
20. Non-nicotinic therapies for smoking cessation.
Siu EC; Tyndale RF
Annu Rev Pharmacol Toxicol; 2007; 47():541-64. PubMed ID: 17209799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
